Search research articles
Contact Us
Filters
Showing results (101-110 of 193) with videos related to
Page
of 20
Sort By:
The Journal of International Medical Research
|
July 13, 2022
Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous <i>UGT1A1*28</i> polymorphism: a single-center case series
Hsiang-Lin Tsai, Po-Jung Chen, Yen-Cheng Chen, et al.
Chemotherapy
|
September 23, 2016
Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment
Ching-Wen Huang, Yung-Sung Yeh, Cheng-Jen Ma, et al.
Oncology Letters
|
April 25, 2025
Effects of first‑line therapies in patients with locally advanced gastrointestinal stromal tumors with <i>KIT</i> and <i>PDGFRα</i> gene mutations: A single‑center study
Wei-Chih Su, Ching-Wen Huang, Yen-Cheng Chen, et al.
World Journal of Surgical Oncology
|
April 13, 2017
Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer
Tzu-Chieh Yin, Hsiang-Lin Tsai, Ping-Fu Yang, et al.
Cancers
|
September 28, 2021
Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
Chun-Ming Huang, Ming-Yii Huang, Hsiang-Lin Tsai, et al.
Biomed Research International
|
January 24, 2014
DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy
Ming-Yii Huang, Chan-Han Wu, Chun-Ming Huang, et al.
Integrative Cancer Therapies
|
October 12, 2023
The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study
Hsiang-Lin Tsai, Yung-Sung Yeh, Po-Jung Chen, et al.
Diagnostics (Basel, Switzerland)
|
June 26, 2026
Wearable Sports Vision Training May Improve Selected Visuomotor Outcomes and Hitting Precision in Collegiate Badminton Athletes: A Randomized Controlled Trial
Yun-Wei Chiang, Jia-Yuan Chang, Chi-Hung Lee, et al.
World Journal of Surgery
|
June 14, 2017
Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy
Ming-Yii Huang, Joh-Jong Huang, Chun-Ming Huang, et al.
Oncology Research
|
February 18, 2022
Comparison of <i>UGT1A1</i> Polymorphism as Guidance of Irinotecan Dose Escalation in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy
Hsiang-Lin Tsai, Yen-Cheng Chen, Tzu-Chieh Yin, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 193) with videos related to
Sort By:
Page
of 20
The Journal of International Medical Research
|
July 13, 2022
Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous <i>UGT1A1*28</i> polymorphism: a single-center case series
Hsiang-Lin Tsai, Po-Jung Chen, Yen-Cheng Chen, et al.
Chemotherapy
|
September 23, 2016
Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment
Ching-Wen Huang, Yung-Sung Yeh, Cheng-Jen Ma, et al.
Oncology Letters
|
April 25, 2025
Effects of first‑line therapies in patients with locally advanced gastrointestinal stromal tumors with <i>KIT</i> and <i>PDGFRα</i> gene mutations: A single‑center study
Wei-Chih Su, Ching-Wen Huang, Yen-Cheng Chen, et al.
World Journal of Surgical Oncology
|
April 13, 2017
Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer
Tzu-Chieh Yin, Hsiang-Lin Tsai, Ping-Fu Yang, et al.
Cancers
|
September 28, 2021
Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
Chun-Ming Huang, Ming-Yii Huang, Hsiang-Lin Tsai, et al.
Biomed Research International
|
January 24, 2014
DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy
Ming-Yii Huang, Chan-Han Wu, Chun-Ming Huang, et al.
Integrative Cancer Therapies
|
October 12, 2023
The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study
Hsiang-Lin Tsai, Yung-Sung Yeh, Po-Jung Chen, et al.
Diagnostics (Basel, Switzerland)
|
June 26, 2026
Wearable Sports Vision Training May Improve Selected Visuomotor Outcomes and Hitting Precision in Collegiate Badminton Athletes: A Randomized Controlled Trial
Yun-Wei Chiang, Jia-Yuan Chang, Chi-Hung Lee, et al.
World Journal of Surgery
|
June 14, 2017
Relationship Between Expression of Proteins ERCC1, ERCC2, and XRCC1 and Clinical Outcomes in Patients with Rectal Cancer Treated with FOLFOX-Based Preoperative Chemoradiotherapy
Ming-Yii Huang, Joh-Jong Huang, Chun-Ming Huang, et al.
Oncology Research
|
February 18, 2022
Comparison of <i>UGT1A1</i> Polymorphism as Guidance of Irinotecan Dose Escalation in <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy
Hsiang-Lin Tsai, Yen-Cheng Chen, Tzu-Chieh Yin, et al.
Page
of 20